Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
S.G. Biopharm is a Mumbai-based pharmaceutical company specializing in the export, wholesale, and supply of a wide range of generic medicinal products. The company focuses on high-demand therapeutic areas including oncology, nephrology, and virology, providing cost-effective alternatives for life-saving treatments such as those for HIV and Hepatitis. They serve a global market by sourcing generic versions of drugs from leading Indian manufacturers and ensuring their distribution to international clients. S.G. Biopharm operates as a key intermediary in the global pharmaceutical supply chain, emphasizing regulatory compliance and supply chain efficiency. The company is ISO 9001:2015 certified and is recognized for its role in enhancing access to affordable healthcare in emerging markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on S.G. Biopharm.